![Robert F. Roscigno](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert F. Roscigno
Präsident bei Robert F. Roscigno Phd Consulting LLC
Aktive Positionen von Robert F. Roscigno
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Robert F. Roscigno Phd Consulting LLC | Präsident | - | - |
Karriereverlauf von Robert F. Roscigno
Ehemalige bekannte Positionen von Robert F. Roscigno
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | 01.12.2017 | 01.07.2020 |
Vero Biotech LLC
![]() Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | 01.01.2009 | 01.09.2015 |
Lung Biotechnology PBC
![]() Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Geschäftsführer | 01.03.2005 | 01.07.2007 |
Präsident | 01.03.2005 | 01.07.2007 | |
UNITED THERAPEUTICS CORPORATION | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Robert F. Roscigno
Duke University | Doctorate Degree |
Trinity College (Connecticut) | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Corporate Officer/Principal | 3 |
President | 2 |
Chief Operating Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
Private Unternehmen | 4 |
---|---|
Vero Biotech LLC
![]() Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Lung Biotechnology PBC
![]() Lung Biotechnology PBC Pharmaceuticals: MajorHealth Technology Lung Biotechnology PBC develops pharmaceutical products. It specializes in clinical trials, lung perfusion, and XenoLung. The company was founded by Martine Rothblatt and is headquartered in Silver Spring, MD. | Health Technology |
Robert F. Roscigno Phd Consulting LLC | |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
- Börse
- Insiders
- Robert F. Roscigno
- Erfahrung